These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
101 related articles for article (PubMed ID: 9949259)
41. [Medical treatment of gastroesophageal reflux by H2 receptor antagonists]. Scarpignato C; Bruley des Varannes S Gastroenterol Clin Biol; 1999 Jan; 23(1 Pt 2):S78-89. PubMed ID: 10078436 [No Abstract] [Full Text] [Related]
42. Adverse effects reported in the use of gastroesophageal reflux disease treatments in children: a 10 years literature review. Cohen S; Bueno de Mesquita M; Mimouni FB Br J Clin Pharmacol; 2015 Aug; 80(2):200-8. PubMed ID: 25752807 [TBL] [Abstract][Full Text] [Related]
43. The Second Canadian Gastroesophageal Reflux Disease Consensus: moving forward to new concepts. Thomson AB; Chiba N; Armstrong D; Tougas G; Hunt RH Can J Gastroenterol; 1998; 12(8):551-6. PubMed ID: 9926265 [TBL] [Abstract][Full Text] [Related]
45. Pharmacological and pharmacodynamic essentials of H(2)-receptor antagonists and proton pump inhibitors for the practising physician. Huang JQ; Hunt RH Best Pract Res Clin Gastroenterol; 2001 Jun; 15(3):355-70. PubMed ID: 11403532 [TBL] [Abstract][Full Text] [Related]
46. [Heartburn: in short-term treatment you have the choice!]. Camain JY; Wiesel PH; Peytremann-Bridevaux I Praxis (Bern 1994); 2012 Feb; 101(5):331-2. PubMed ID: 22377981 [No Abstract] [Full Text] [Related]
47. Metoclopramide, H2 blockers, and proton pump inhibitors: pharmacotherapy for gastroesophageal reflux in neonates. Malcolm WF; Cotten CM Clin Perinatol; 2012 Mar; 39(1):99-109. PubMed ID: 22341540 [TBL] [Abstract][Full Text] [Related]
48. Medical therapy for gastroesophageal reflux disease. Arora AS; Castell DO Mayo Clin Proc; 2001 Jan; 76(1):102-6. PubMed ID: 11155401 [TBL] [Abstract][Full Text] [Related]
50. Medical management vs. surgery for gastroesophageal reflux disease. Kripke C Am Fam Physician; 2010 Aug; 82(3):244. PubMed ID: 20672787 [No Abstract] [Full Text] [Related]
51. Dyspepsia and reflux in primary care: rough DIAMOND of a trial. van Zanten SV Lancet; 2009 Jan; 373(9659):187-8. PubMed ID: 19150689 [No Abstract] [Full Text] [Related]
52. [Night acid "bursting": treatment of patients with gastroesophageal reflux disease]. Vasil'ev IuV; Beliaeva VS Eksp Klin Gastroenterol; 2007; (3):83-91. PubMed ID: 17937011 [No Abstract] [Full Text] [Related]
53. The pharmacological management of gastroesophageal reflux disease. Lowe RC; Wolfe MM Minerva Gastroenterol Dietol; 2004 Sep; 50(3):227-37. PubMed ID: 15729198 [TBL] [Abstract][Full Text] [Related]
54. [Maintenance therapy of mild form of GERD by H2 receptor antagonists]. Kurosawa S Nihon Rinsho; 2000 Sep; 58(9):1859-64. PubMed ID: 11004816 [TBL] [Abstract][Full Text] [Related]
55. Diagnosis and Treatment of Gastroesophageal Reflux in Infants and Children. Baird DC; Harker DJ; Karmes AS Am Fam Physician; 2015 Oct; 92(8):705-14. PubMed ID: 26554410 [TBL] [Abstract][Full Text] [Related]
56. Novel pharmaceutical approaches to reflux disease. Dutta U; Armstrong D Gastroenterol Clin North Am; 2013 Mar; 42(1):93-117. PubMed ID: 23452633 [TBL] [Abstract][Full Text] [Related]
57. Efficacy of H2 receptor antagonists in the treatment of gastroesophageal reflux disease and its symptoms. Tougas G; Armstrong D Can J Gastroenterol; 1997 Sep; 11 Suppl B():51B-54B. PubMed ID: 9347179 [TBL] [Abstract][Full Text] [Related]